<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lecendreux M</submitter><funding>Agence Nationale de la Recherche</funding><pagination>e0169836</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5249232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Narcolepsy is a rare neurologic disorder characterized by excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep patterns. Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low CSF-hypocretin levels (&lt;110 pg/ml). This specific loss of hypocretin and the strong association with the HLA-DQB1*06:02 allele led to the hypothesis that NT1 could be an immune-mediated pathology. Moreover, susceptibility to NT1 has recently been associated with several pathogens, particularly with influenza A H1N1 virus either through infection or vaccination. The goal of this study was to compare peripheral blood immune cell populations in recent onset pediatric NT1 subjects (post or non-post 2009-influ</pubmed_abstract><journal>PloS one</journal><pubmed_title>Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.</pubmed_title><pmcid>PMC5249232</pmcid><funding_grant_id>PHRC AOM07-138, Narcobank</funding_grant_id><funding_grant_id>ANR-11-IDEX-0004-02</funding_grant_id><pubmed_authors>Regnault A</pubmed_authors><pubmed_authors>Pitoiset F</pubmed_authors><pubmed_authors>Churlaud G</pubmed_authors><pubmed_authors>Lecendreux M</pubmed_authors><pubmed_authors>Klatzmann D</pubmed_authors><pubmed_authors>Tran TA</pubmed_authors><pubmed_authors>Liblau R</pubmed_authors><pubmed_authors>Rosenzwajg M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.</name><description>Narcolepsy is a rare neurologic disorder characterized by excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep patterns. Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low CSF-hypocretin levels (&lt;110 pg/ml). This specific loss of hypocretin and the strong association with the HLA-DQB1*06:02 allele led to the hypothesis that NT1 could be an immune-mediated pathology. Moreover, susceptibility to NT1 has recently been associated with several pathogens, particularly with influenza A H1N1 virus either through infection or vaccination. The goal of this study was to compare peripheral blood immune cell populations in recent onset pediatric NT1 subjects (post or non-post 2009-influ</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-18T23:57:35.258Z</modification><creation>2019-03-26T22:51:35Z</creation></dates><accession>S-EPMC5249232</accession><cross_references><pubmed>28107375</pubmed><doi>10.1371/journal.pone.0169836</doi></cross_references></HashMap>